Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT01038778 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01038778
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Metastatic Kidney Carcinoma Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7

Start date: 2009-10-29
Primary completion: 2019-05-22
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.